Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Counseling × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Neoplasms 4 Overweight 3 Obesity 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Sleep Wake Disorders 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia 2 Hematopoietic and Lymphoid System Neoplasm 2 Hematologic Neoplasms 2 Fatigue 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity-Related Malignant Neoplasm 1 No Evidence of Disease 1 Neoplasm Metastasis 1 Motor Activity 1 Metastatic Pancreatic Adenocarcinoma 1 Leukemia, Myeloid, Acute 1 Intermittent Fasting 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Carcinoma 1

Interventions

Taxes 4 Paclitaxel 3 Cyclophosphamide 3 exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Doxorubicin 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 romidepsin 1 ribociclib 1 pegfilgrastim 1 entinostat 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Trastuzumab 1 Psychiatric Rehabilitation 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Lapatinib 1 Indomethacin 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡